Healthcare -
Biotechnology - NASDAQ - US
$ 0.84
-0.838 %
$ 65.7 M
Market Cap
5.25
P/E
CTMX - REVENUE
Revenue CTMX - CytomX Therapeutics, Inc.
101 M
LAST VALUE
20.61%
2 YEAR CAGR
11.21%
5 YEAR CAGR
60.58%
10 YEAR CAGR